Inventor · disambiguated record
Mohamed Seleem
Also filed as: SELEEM MOHAMED · SELEEM MOHAMED NAGUIEB
21 granted patents·9 pending applications·12 citations·filing 2013–2025
90Inventor score
Files withPURDUE RESEARCH FOUNDATION28CUSHMAN MARK STANLEY1VIRGINIA TECH INTELLECTUAL PROPERTIES INC1
Top patents by PatentIndex Score
30 records- 0191US10265408B2Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptidePURDUE RESEARCH FOUNDATION·Filed 2018·Granted Apr 23, 2019·5 cites·14 claims
- 0284US11091437B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 17, 2021·1 cites·4 claims
- 0380US11731964B2Benzamide antibacterial agentsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 22, 2023·2 cites·12 claims
- 0478US10364224B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2016·Granted Jul 30, 2019·1 cites·10 claims
- 0574US11231371B2Method for the determination of antibiotic susceptibility through stimulated Raman metabolic imagingPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Jan 25, 2022·1 cites·12 claims
- 0674US11098014B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 24, 2021·0 cites·8 claims
- 0773US12459936B2Benzamide antibacterial agentsPURDUE RESEARCH FOUNDATION·Filed 2023·Granted Nov 4, 2025·0 cites·14 claims
- 0873US10414759B2Phenylthiazoles and uses thereofPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Sep 17, 2019·1 cites·15 claims
- 0973US2025328351A1Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteriaPURDUE RESEARCH FOUNDATION·Filed 2025·Application pending·0 cites
- 1070US9353072B2Antimicrobial substituted thiazoles and methods of useCUSHMAN MARK STANLEY·Filed 2013·Granted May 31, 2016·1 cites·5 claims
- 1169US11198674B2Aryl isonitriles as a new class of antimicrobial compoundsPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Dec 14, 2021·0 cites·5 claims
- 1265US10688192B2Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptidePURDUE RESEARCH FOUNDATION·Filed 2019·Granted Jun 23, 2020·0 cites·14 claims
- 1365US2024066022A1Diiodohydroxyquinoline for the treatment of clostridium difficile infectionPURDUE RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 1464US2025281464A1Treatment of pathogenic neisseria sp. infection with triazole antifungal agentsVIRGINIA TECH INTELLECTUAL PROPERTIES INC·Filed 2023·Application pending·0 cites
- 1558US11806342B2Diiodohydroxyquinoline for the treatment of clostridium difficile infectionPURDUE RESEARCH FOUNDATION·Filed 2020·Granted Nov 7, 2023·0 cites·6 claims
- 1657US12378211B2Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteriaPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Aug 5, 2025·0 cites·12 claims
- 1757US10138252B1LactonesPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Nov 27, 2018·0 cites·5 claims
- 1857US2022213047A1Carbonic anhydrase inhibitors for treatment of neisseria gonorrhoeae infectionPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 1956US10087190B1LactonesPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Oct 2, 2018·0 cites·5 claims
- 2054US10875895B2Antibacterial cell-penetrating peptidesPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Dec 29, 2020·0 cites·15 claims
- 2154US9801861B2Antimicrobial substituted thiazoles and methods of usePURDUE RESEARCH FOUNDATION·Filed 2016·Granted Oct 31, 2017·0 cites·10 claims
- 2253US2025195490A1Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)PURDUE RESEARCH FOUNDATION·Filed 2023·Application pending·0 cites
- 2351US2020306295A1METHOD AND DEVICE FOR ANNIHILATION OF Staphylococcus aureusPURDUE RESEARCH FOUNDATION·Filed 2019·Application pending·0 cites
- 2451US2023183773A1Method for the determination of antibiotic susceptibility through stimulated raman metabolic imagingPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 2550US11013933B2Method and device for annihilation of methicillin-resistant Staphylococcus aureusPURDUE RESEARCH FOUNDATION·Filed 2018·Granted May 25, 2021·0 cites·11 claims
- 2649US10449174B2Aryl isonitrile compounds as a new class of potent, broad-spectrum antifungal compoundsPURDUE RESEARCH FOUNDATION·Filed 2017·Granted Oct 22, 2019·0 cites·6 claims
- 2749US9604925B2Class II HMG-CoA reductase inhibitors and methods of usePURDUE RESEARCH FOUNDATION·Filed 2015·Granted Mar 28, 2017·0 cites·14 claims
- 2849US2025339401A1Methods and materials for treatment of neisseria gonorrhoeae infectionPURDUE RESEARCH FOUNDATION·Filed 2022·Application pending·0 cites
- 2947US2021317099A1Safer, potent, and fast acting antimicrobial agentsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 3045US10301664B2Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infectionsPURDUE RESEARCH FOUNDATION·Filed 2016·Granted May 28, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Mohamed Seleem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →